Description

2-[2-(2,3-Dimethyl-Imidazo[1,2-B][1,2,4]Triazin-7-Yl)-Ethyl]-Isoindole-1,3-Dione is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and development programs.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, especially in oncology and antiviral research.
• Organic Synthesis Building Block: Used in medicinal chemistry for constructing complex fused heterocyclic systems with potential biological activity.
• Research & Development (R&D): Serves as a standard or investigational compound in academic and industrial research laboratories for structure-activity relationship (SAR) studies.
• API Manufacturing: Employed in the scaled-up production of target molecules during the later stages of pharmaceutical development.
• Biochemical Research: Potential use as a tool compound or probe in biochemical assays to study specific enzyme or receptor interactions.

Basic Information

Product Name	2-[2-(2,3-Dimethyl-Imidazo[1,2-B][1,2,4]Triazin-7-Yl)-Ethyl]-Isoindole-1,3-Dione
CAS No.	1170459-36-5
Molecular Formula	C₁₇H₁₅N₅O₂
Molecular Weight	321.34 g/mol
Synonyms	2-[2-(2,3-Dimethylimidazo[1,2-b][1,2,4]triazin-7-yl)ethyl]-1H-isoindole-1,3(2H)-dione; 2-(2-(2,3-Dimethylimidazo[1,2-b][1,2,4]triazin-7-yl)ethyl)isoindoline-1,3-dione; 1170459-36-5; 2,3-Dimethyl-7-(2-(1,3-dioxoisoindolin-2-yl)ethyl)imidazo[1,2-b][1,2,4]triazine; N-(2-(2,3-Dimethylimidazo[1,2-b][1,2,4]triazin-7-yl)ethyl)phthalimide
EINECS	Contact for details

Quality Control

Our 2-[2-(2,3-Dimethyl-Imidazo[1,2-B][1,2,4]Triazin-7-Yl)-Ethyl]-Isoindole-1,3-Dione is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain stability. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any single impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.